IFNA1 and systemic lupus erythematosus: The researchers found that the IFN signature recognized in PBMCs of SLE patients seemed to be more sensitive to the activation of the IFN pathway than serum IFN-α levels (33), that’s maybe why most studies focused on detecting the transcriptional levels of ISGs in peripheral blood to find candidate biomarkers for diagnosis and treatment of SLE patients.